Articles

Elsevier, Physics and Chemistry of the Earth, Volume 126, June 2022
The Zambezi Riparian Region (ZRR) is a lifeline and home to ∼40 million people who depend heavily on the river basin for their livelihood. It also furnishes 8 of its riparian countries with goods and services on which hydropower production and food security anchor. The sustainability of the ZRR is threatened by extreme climate events. Here, we interrogate consecutive dry days (CDDs), an effective metric of extreme climatic events with implications on drought-driven water availability. We use ensemble empirical mode decomposition (EEMD) to understand CDDs.
Elsevier, Digestive and Liver Disease, Volume 54, June 2022
Patients with liver diseases, especially those with cirrhosis, have an increased mortality risk when infected by SARS-CoV-2 and therefore anti-SARS-CoV-2 vaccine has been recommended by leading Scientific Associations for all patients with chronic liver diseases. However, previous reports have shown a reduced antibody response following the full course of vaccination in immunosuppressed patients, including liver transplant recipients and several rheumatic diseases.
Elsevier, Clinics and Research in Hepatology and Gastroenterology, Volume 46, 1 June 2022
Background and aims: The risk prediction of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) is a challenge especially in the era of antiviral therapy. The aim of this meta-analysis was to comprehensively evaluate the performance of existing HCC prediction scores in HCC prediction on antivirals. Methods: We searched PubMed, Web of Science and Cochrane Library for relevant prospective studies from the inception to August 24, 2021.
Elsevier,

eClinicalMedicine, Volume 48, June 2022

Background: Abatacept is a selective T-cell costimulation modulator approved for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis. Reports were recently published on hepatitis B virus reactivation (HBVr) in patients who were treated with abatacept. However, the literature is limited to case reports and series, and no study has investigated the relationship between HBVr and abatacept using extensive population-based databases.

Elsevier,

Clinical Breast Cancer, Volume 22, June 2022

This study explores the current status and problems of breast cancer treatment with schizophrenia, including advanced stage diagnosis. It finds that patients with schizophrenia with reduced ADL are less likely to receive chemotherapy or recommended cancer treatment, and as such it is highly recommended that they breast cancer screening so that they can be diagnosed early and treated adequately.
Elsevier,

Public Health in Practice, Volume 3, June 2022

Focused on mental health of young people and how it was impacted by the COVID-19 pandemic. Links to good health and wellbeing for all.
Elsevier,

Journal of Transport and Health, Volume 25, June 2022

The article looks at the effects on mental health when accessibility was limited during COVID-19 containment policies.
Methodological summary for projecting future VSL-based economic burden of ADRDs (Model 1).
Elsevier
An article on the economic burden of Alzheimer's disease and related dementias, in the context of SDG 3, focusing specifically on the global, regional, and national estimates from 2019 to 2050.
Elsevier,

The Lancet Healthy Longevity, Volume 3, June 2022

An Article on dementia risk factors, in the context of SDG 3, focusing specifically on whether cardiac multimorbidity increases dementia risk.

Pages